It has been largely demonstrated that pathogenic mutations in the BRCA1 and BRCA2 genes increase the risk of developing breast cancer, respectively, by 65% and 45%, and are responsible for 90% of all hereditary BC cases [4]. This evidence concerns the gene BRCA2 and breast cancer.